CD79A and infection: The induction of α4β7+ IgG and IgA secreting B cells post-immunization may offer a mechanistic explanation of the protection afforded by the bioconjugate vaccine as LPS-specific B cells may home to the gut and produce antibodies at the site of infection, which can be actively secreted (IgA) or passively transudated (IgG) into the lumen.